An evidence-based review and guidelines for patient self-testing and management of oral anticoagulation

British Journal of Haematology

Volumn 131, Issue 2, 2005, Pages 156-165

  Fitzmaurice, D A ^a   Gardiner, C ^b   Kitchen, S ^c   Mackie, I ^b   Murray, E T ^a   Machin, S J ^b  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c UK NEQAS for Blood Coagulation   (United Kingdom)

Author keywords

Anticoagulation; Guidelines; Self management; Self testing

Indexed keywords

ANTICOAGULANT AGENT; HEPARIN; VACCINE; WARFARIN;

ANTICOAGULATION; BLEEDING; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; CONSENSUS; COST EFFECTIVENESS ANALYSIS; FOLLOW UP; HUMAN; PATIENT SELECTION; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITY CONTROL; RELIABILITY; REVIEW; SELF EVALUATION; SIDE EFFECT; TRAINING; UNITED KINGDOM; BLOOD; CONTROLLED CLINICAL TRIAL; DRUG SELF ADMINISTRATION; HEALTH CARE QUALITY; INTERNATIONAL NORMALIZED RATIO; RANDOMIZED CONTROLLED TRIAL; THROMBOEMBOLISM;

ANTICOAGULANTS; GREAT BRITAIN; HUMANS; INTERNATIONAL NORMALIZED RATIO; PRACTICE GUIDELINES; QUALITY ASSURANCE, HEALTH CARE; RANDOMIZED CONTROLLED TRIALS; SELF ADMINISTRATION; THROMBOEMBOLISM; WARFARIN;

EID: 32944461778     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2005.05739.x     Document Type: Review

References (41)

1. Anderson D.R. Harrison L. Hirsh J. ( 1993) Evaluation of a portable prothrombin time monitor for home use by patients who require long-term oral anticoagulant therapy. Archives of Internal Medicine, 153, 1441 1447.
2. Ansell J.E. Patel N. Ostrovsky D. Nozzolillo E. Peterson A.M. ( 1995) Long term patient self management of oral anticoagulation. Archives of Internal Medicine, 155, 2185 2189.
3. Barnado A. ( 1995) Experience with patient self-management of oral anticoagulation. Journal of Thrombosis and Thrombolysis, 2, 321 325.
4. Bisley C. ( 1997) A day in the life of an asthma nurse. Asthma Journal, 2, 152 154.
5. British Society for Haematology, British Committee for Standards in Haematology Haemostasis and Thrombosis Task Force ( 1998) Guidelines on oral anticoagulation: third edition. British Journal of Haemotology, 101, 374 387.
6. Cosmi B. Palareti G. Carpanedo M. Pengo V. Biasiolo A. Rampazzo P. Morstabilini G. Testa S. ( 2000) Assessment of patient capability to self-adjust oral anticoagulant dose: a multicenter study on home use of portable prothrombin time monitor (COAGUCHEK). Haematologica, 85, 826 831.
7. Cromheecke M.E. Levi M. Colly L.P. de Mol B.J.M. Prins M.H. Hutten B. Mak R. Keyzers K.C.J. Buller H. ( 2000) Oral anticoagulation self-management by a specialist anticoagulation clinic: a randomised cross-over comparison. Lancet, 356, 97 102.
8. England J.M. Hyde K. Lewis S.M. Mackie I.J. Rowan R.M. ( 1995) Guidelines for near patient testing: haematology. Clinical and Laboratory Haematology, 17, 301 310.
9. Fitzmaurice D.A. Machin S.J. ( 2001) Recommendations for patients undertaking self management of oral anticoagulation. British Medical Journal, 323, 985 989.
10. Fitzmaurice D.A. Hobbs F.D.R. Murray E.T. Bradley C.P. Holder R. ( 1996) Evaluation of computerised decision support for oral anticoagulation management based in primary care. British Journal of General Practice, 46, 533 535.
11. Fitzmaurice D.A. Murray E.T. Gee K.M. Allan T.F. Hobbs F.D.R. ( 2002) A randomised controlled trial of patient self-management of oral anticoagulation treatment compared with primary care management. Journal of Clinical Pathology, 55, 845 849.
12. Gadisseur A.P. Breukink-Engbers W.G. van der Meer F.J. van den Besselaar A.M. Sturk A. Rosendaal F.R. ( 2003) Comparison of the quality of oral anticoagulant therapy through patient self-management and management by specialized anticoagulation clinics in the Netherlands: a randomised clinical trial. Archives of Internal Medicine, 163, 2639 2646.
13. Gardiner C. Williams K. Mackie I.J. Machin S.J. Cohen H. ( 2004) Patient self-testing is a reliable and acceptable alternative to laboratory INR monitoring. British Journal of Haematology, 128, 242 247.
14. Gustafson C. Asplund K. Britton M. Norrving B. Olsson B. Marke L.A. ( 1992) Cost effectiveness of primary prevention in atrial fibrillation: Swedish national perspective. British Medical Journal, 305, 1457 1460.
15. Hasenkam J.M. Knudsen L. Kimose H.H. Gronnesby H. Atterman J. Anderson N.T. Pilegaard H.K. ( 1997a) Practicability of patient self testing of oral anticoagulant therapy by the international normalized ratio (INR) using a portable whole blood monitor (Brief communication). Thrombosis Research, 85, 77 82.
16. Hasenkam J.M. Kimose H.H. Knudsen L. Gronnesby H. Halborg J. Christensen T.D. Atterman J. Pilegaard H.K. ( 1997b) Self management of oral anticoagulation therapy after heart valve replacement. European Journal of Cardio-thoracic Surgery, 11, 935 942.
17. Hobbs F.D.R. ( 1996) Near patient testing in primary care. British Medical Journal, 312, 263 264.
18. Kapiotis S. Quehenberger P. Speiser W. ( 1995) Evaluation of the new method Coagucheck for the determination of the prothrombin time from capillary blood: comparison with thrombo test on KC-1. Thrombosis Research, 77, 563 567.
19. Kitchen S. Preston F.E. ( 1996) Monitoring oral anticoagulant therapy with the TAS near patient test system: comparison with conventional thromboplastins. Journal of Clinical Pathology, 50, 951 956.
20. Kitchen S. Walker I.D. Woods T.A.L. Preston F.E. ( 1994) Thromboplastin related differences in the determination of international normalised ratios: a cause for concern?. Thrombosis and Haemostasis, 72, 426 429.
21. Kitchen S. Kitchen D.P. Jennings I. Woods T.A.L. Preston F.E. ( 2005) Point of care international normalised ratio: UK National External Quality Assessment Scheme experience demonstrates necessity for proficiency testing of 3 different monitors. Journal of Thrombosis Haemostasis ( in press Kortke H. ( 2001) ESCAT early self controlled anticoagulation trial. Annals of Thoracic Surgery, 72, 44 48.
22. Kurnitz J. ( 1998) The view from the inside: personal reflections. Journal of Thrombosis and Thrombolysis, 5, S49 S51.
23. Lowe G.D.O. ( 1992) Anti-thrombotic treatment and atrial fibrillation (Editorial). British Medical Journal, 305, 1445 1446.
24. Machin S.J. Mackie I.J. Chitolie A. Lawrie A.S. ( 1996) Near patient testing (near-patient testing) in haemostasis - a synoptic review. Clinical and Laboratory Haematology, 18, 69 74.
25. Massicotte P. Marzinotto V. Vegh P. Adams M. Andrew M. ( 1995) Home monitoring of warfarin therapy in children with a whole blood monitor. The Journal of Paediatrics, 127, 389 394.
26. Medical Devices Agency ( 2002) Management and Use of IVD Point of Care Test Devices. MDA DB2002 (03). Medical Devices Agency, Department of Health, London.
27. Murray E.T. Kitchen D.P. Kitchen S. Jennings I. Woods T.A.L. Preston F.E. Fitzmaurice D.A. ( 2003) Patient self management of oral anticoagulation and external quality assessment procedures. British Journal of Haematology, 122, 825 828.
28. Murray E.T. Fitzmaurice D.A. McCahon D. Fuller C. Sandhur H. ( 2004) Training for patients in a randomised controlled trial of self-management of warfarin treatment. British Medical Journal, 328, 437 438.
29. NCCLS ( 2004) Point of Care Monitoring of Anticoagulation Therapy; Approved Guideline H49-A. NCCLS. Clinical and Laboratory Standards Institute, Wayne, PA, USA Gresalfi N.J. ( 1991) Dry reagent technology for rapid, convenient measurements of blood coagulation and fibrinolysis. Clinical Chemistry, 37, 520 526.
30. Rink E. Hilton S. Szczepura A. Fletcher J. Sibbald J. Davies C. Freeling P. Stilwell J. ( 1993) Impact of introducing near patient testing for standard investigations in general practice. British Medical Journal, 307, 775 778.
31. Rose P. ( 1996) Audit of anticoagulant therapy. Journal of Clinical Pathology, 49, 5 9.
32. Sandercock P. Bamford J. Dennis M. Burn J. Slattery J. Jones L. ( 1992) Atrial fibrillation and stroke: prevalence in different types of stroke and influence on early and long term prognosis (Oxfordshire Community Stroke Project). British Medical Journal, 305, 1460 1465.
33. Sawicki P.T. ( 1999) A structured teaching and self-management program for patients receiving oral anticoagulation. A randomized controlled trial. Journal of American Medical Association, 281, 145 150.
34. Sidhu P. O'Kane H.O. ( 2001) Self-managed anticoagulation: Results from a two-year prospective randomised trial with heart valve patients. Annals of Thoracic Surgery, 72, 1523 1527.
35. Stamper G. Toth P. ( 1996) Patient self testing for prothrombin time using the Coaguchek system - a feasibility study. Clinical Chemistry, 42, 10.1 10.7.
36. Sudlow C.M. Rodgers H. Kenny R.A. Thomson R.G. ( 1995) Service provision and use of anticoagulants in atrial fibrillation. British Medical Journal, 311, 558 561.
37. Sweeney K.G. Pereira-Gray D. Steele R. Evans P. ( 1995) Use of warfarin in non-rheumatic atrial fibrillation: a commentary from general practice. British Journal of General Practice, 45, 153 158.
38. Taborski V.W.E. Wittstamm F.J. Bernada A. ( 1999) Cost-effectiveness of self-management anticoagulant therapy in Germany. Seminars in Thrombosis and Haemostasis, 25, 10 107.
39. Taylor F. Ramsey M. Voke J. Cohen H. ( 1993) GPs not prepared for monitoring anticoagulation. British Medical Journal, 307, 1493.
40. Tripodi A. Bressi C. Carpenedo M. Chantarangkul V. Clerici M. Mannucci P.M. ( 2004) Quality assurance program for whole blood prothrombin time-international normalised ratio point-of-care monitors used for patient self-testing to control oral anticoagulation. Thrombosis Research, 113, 35 40.
41. White R. McCurdy S.A. von Marensdorff H. Woodruff D.E. Leftgoff P.A. ( 1989) Home prothrombin time monitoring after the initiation of warfarin therapy. Annals of Internal Medicine, 111, 730 736.